187 related articles for article (PubMed ID: 16710322)
1. Facilitation of cardiac vagal activity by CRF-R1 antagonists during swim stress in rats.
Wood SK; Verhoeven RE; Savit AZ; Rice KC; Fischbach PS; Woods JH
Neuropsychopharmacology; 2006 Dec; 31(12):2580-90. PubMed ID: 16710322
[TBL] [Abstract][Full Text] [Related]
2. The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats.
Jutkiewicz EM; Wood SK; Houshyar H; Hsin LW; Rice KC; Woods JH
Psychopharmacology (Berl); 2005 Jul; 180(2):215-23. PubMed ID: 15696320
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing hormone modulates airway vagal preganglionic neurons of Sprague-Dawley rats at multiple synaptic sites via activation of its type 1 receptors: Implications for stress-associated airway vagal excitation.
Guo Y; Yan X; Chen X; He D; Zeng M; Chen Y; Xia C; Qiu D; Wang J
Neuroscience; 2017 Jul; 355():101-112. PubMed ID: 28499969
[TBL] [Abstract][Full Text] [Related]
4. The corticotropin-releasing factor (CRF)(1) receptor antagonists CP154,526 and DMP695 inhibit light-induced phase advances of hamster circadian activity rhythms.
Gannon RL; Millan MJ
Brain Res; 2006 Apr; 1083(1):96-102. PubMed ID: 16551464
[TBL] [Abstract][Full Text] [Related]
5. Role of corticotropin-releasing factor receptors type 1 and 2 in modulating the rat adrenocorticotropin response to stressors.
Rivier CL; Grigoriadis DE; Rivier JE
Endocrinology; 2003 Jun; 144(6):2396-403. PubMed ID: 12746300
[TBL] [Abstract][Full Text] [Related]
6. Evidence of lasting dysregulation of neuroendocrine and HPA axis function following global cerebral ischemia in male rats and the effect of Antalarmin on plasma corticosterone level.
de la Tremblaye PB; Raymond J; Milot MR; Merali Z; Plamondon H
Horm Behav; 2014 Mar; 65(3):273-84. PubMed ID: 24444675
[TBL] [Abstract][Full Text] [Related]
7. The effect of a corticotropin-releasing factor receptor 1 antagonist on the fear conditioning response in low- and high-anxiety rats after chronic corticosterone administration.
Skórzewska A; Wisłowska-Stanek A; Lehner M; Turzyńska D; Sobolewska A; Krząścik P; Szyndler J; Maciejak P; Płaźnik A
Stress; 2019 Jan; 22(1):113-122. PubMed ID: 30345859
[TBL] [Abstract][Full Text] [Related]
8. CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis.
Lowery EG; Spanos M; Navarro M; Lyons AM; Hodge CW; Thiele TE
Neuropsychopharmacology; 2010 May; 35(6):1241-52. PubMed ID: 20130533
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin-releasing hormone antagonists, astressin B and antalarmin: differing profiles of activity in rhesus monkeys.
Broadbear JH; Winger G; Rivier JE; Rice KC; Woods JH
Neuropsychopharmacology; 2004 Jun; 29(6):1112-21. PubMed ID: 14997174
[TBL] [Abstract][Full Text] [Related]
10. Restraint stress stimulates colonic motility via central corticotropin-releasing factor and peripheral 5-HT3 receptors in conscious rats.
Nakade Y; Fukuda H; Iwa M; Tsukamoto K; Yanagi H; Yamamura T; Mantyh C; Pappas TN; Takahashi T
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1037-44. PubMed ID: 17158256
[TBL] [Abstract][Full Text] [Related]
11. Corticotrophin releasing factor receptor 1 antagonists prevent chronic stress-induced behavioral changes and synapse loss in aged rats.
Dong H; Keegan JM; Hong E; Gallardo C; Montalvo-Ortiz J; Wang B; Rice KC; Csernansky J
Psychoneuroendocrinology; 2018 Apr; 90():92-101. PubMed ID: 29477954
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing factor type 1 receptors mediate the visceral hyperalgesia induced by repeated psychological stress in rats.
Larauche M; Bradesi S; Million M; McLean P; Taché Y; Mayer EA; McRoberts JA
Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G1033-40. PubMed ID: 18308857
[TBL] [Abstract][Full Text] [Related]
13. Analgesia and hyperalgesia from CRF receptor modulation in the central nervous system of Fischer and Lewis rats.
Vit JP; Clauw DJ; Moallem T; Boudah A; Ohara PT; Jasmin L
Pain; 2006 Apr; 121(3):241-260. PubMed ID: 16495007
[TBL] [Abstract][Full Text] [Related]
14. Intracerebroventricular administration of corticotrophin-releasing hormone receptor antagonists produces different effects on hypothalamic pituitary adrenal responses to novel restraint depending on the stress history of the animal.
Vining C; Iyer V; Bhatnagar S
J Neuroendocrinol; 2007 Mar; 19(3):198-207. PubMed ID: 17280593
[TBL] [Abstract][Full Text] [Related]
15. Human urocortin II, a new CRF-related peptide, displays selective CRF(2)-mediated action on gastric transit in rats.
Million M; Maillot C; Saunders P; Rivier J; Vale W; Taché Y
Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G34-40. PubMed ID: 11751155
[TBL] [Abstract][Full Text] [Related]
16. Swim stress excitation of nucleus incertus and rapid induction of relaxin-3 expression via CRF1 activation.
Banerjee A; Shen PJ; Ma S; Bathgate RA; Gundlach AL
Neuropharmacology; 2010 Jan; 58(1):145-55. PubMed ID: 19560474
[TBL] [Abstract][Full Text] [Related]
17. Peripheral CRF-R1/CRF-R2 antagonist, astressin C, induces a long-lasting blockade of acute stress-related visceral pain in male and female rats.
Larauche M; Erchegyi J; Miller C; Sim MS; Rivier J; Behan D; Taché Y
Peptides; 2022 Nov; 157():170881. PubMed ID: 36185037
[TBL] [Abstract][Full Text] [Related]
18. Acute stress-induced sensitization of the pituitary-adrenal response to heterotypic stressors: independence of glucocorticoid release and activation of CRH1 receptors.
Belda X; Daviu N; Nadal R; Armario A
Horm Behav; 2012 Sep; 62(4):515-24. PubMed ID: 22986335
[TBL] [Abstract][Full Text] [Related]
19. [Analgesic effect of corticotropin releasing factor (CRF) on somatic pain sensitivity: participation of glucocorticoid and CRF-2 receptors].
Iarushkina NI; Bagaeva TR; Filaretova LP
Ross Fiziol Zh Im I M Sechenova; 2008 Oct; 94(10):1118-25. PubMed ID: 19065825
[TBL] [Abstract][Full Text] [Related]
20. Effect of corticotropin-releasing factor receptor antagonist on psychologically suppressed masculine sexual behavior in rats.
Miwa Y; Nagase K; Oyama N; Akino H; Yokoyama O
J Sex Med; 2011 Mar; 8(3):688-95. PubMed ID: 20946165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
